Actively Recruiting

Phase 4
Age: 18Years - 35Years
FEMALE
Healthy Volunteers
NCT07092527

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

Led by University of California, San Diego · Updated on 2026-01-15

80

Participants Needed

1

Research Sites

155 weeks

Total Duration

On this page

Sponsors

U

University of California, San Diego

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.

CONDITIONS

Official Title

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

Who Can Participate

Age: 18Years - 35Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent form
  • Willingness to comply with all study procedures and be available for the full study duration
  • Aged 18 to 35 years
  • For transgender/non-binary group: plan to start testosterone therapy and history of regular menstrual cycles every 24-35 days before starting therapy
  • For cisgender female group: regular menstrual cycles every 24-35 days
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding within two months of study enrollment
  • Incarcerated or institutionalized with cognitive impairment
  • Hemoglobin less than 11 gm/dl at screening
  • Weighing less than 110 pounds
  • Body mass index less than 18 or greater than 35
  • Current endocrine diseases including untreated thyroid problems, pituitary or adrenal disease, polycystic ovary syndrome, or androgen-producing tumors
  • Diabetes or kidney, liver, or heart disease
  • History of ovary or uterus removal surgery
  • History of brain or pelvic surgery or radiation
  • Currently taking medications affecting reproductive hormones such as contraceptives, androgens, estrogens, progestins, GnRH antagonists, insulinomimetics, or metformin
  • Prior testosterone therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of California, San Diego

San Diego, California, United States, 92037

Actively Recruiting

Loading map...

Research Team

A

Antoni Duleba, MD

CONTACT

M

Marisa Hildebrand, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here